GlassScriptPhysician profile
Sherri Levin
NPI 1013951128
$6,513.71
in general payments reported to CMS, 2019-2025
47 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,382 · 2020: $1,572 · 2021: $842 · 2022: $673 · 2023: $978 · 2024: $784 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $1,162.64 | 2020-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Intuitive Surgical, INC. | $785.04 | 2019-2020 | |
| Abbvie INC. | $463.24 | 2019-2025 | |
| Astellas Pharma US INC | $391.97 | 2020-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $342.16 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $315.06 | 2019-2025 | Slynd |
| Caldera Medical, INC | $313.99 | 2021-2023 | Desara |
| Pfizer INC. | $237.36 | 2022-2025 | |
| Amag Pharmaceuticals, INC. | $197.88 | 2019-2020 | |
| Therapeuticsmd, INC. | $170.47 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $161.81 | 2021-2025 | |
| Myovant Sciences INC. | $161.47 | 2021-2022 | |
| Millicent US INC | $150.99 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Biogen, INC. | $134.42 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $118.73 | 2020-2023 | Affirm Prone Biopsy System, Aptima, Thinprep 2000 Processor |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $107.82 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.66 | 2019-2021 | |
| Coopersurgical, INC. | $106.23 | 2019-2023 | Paragard T 380a |
| Medtronic, INC. | $105.97 | 2023 | Polysorb, Truclear, V-Loc 180 |
| Baxter Healthcare | $99.60 | 2024 | Perclot, Floseal |
| Allergan, INC. | $82.84 | 2019-2020 | |
| Dysis Medical, INC. | $71.55 | 2020 | |
| Ascend Therapeutics US, LLC | $63.85 | 2020-2023 | |
| Avion Pharmaceuticals | $62.74 | 2019-2021 | |
| Acessa Health INC. | $60.07 | 2019 | |
| Alafair Biosciences, INC. | $57.09 | 2024 | Versawrap |
| Ethicon US, LLC | $50.05 | 2020-2023 | Ethicon, Stratafix, Evarrest |
| Duchesnay USA Incorporated | $43.92 | 2019 | |
| Organon LLC | $42.67 | 2022-2024 | |
| Applied Medical Resources Corporation | $33.51 | 2022 | |
| Medicem INC. | $31.08 | 2020-2021 | |
| Aspira Women'S Health INC | $24.39 | 2024 | Ova1 |
| Becton, Dickinson and Company | $23.42 | 2024 | Arista Ah Flexitip |
| Optumhealth Care Solutions, LLC | $21.33 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Covidien LP | $20.42 | 2019 | |
| Roche Diagnostics Corporation | $19.27 | 2019 | |
| Evofem Biosciences, INC. | $18.15 | 2020 | |
| Biom'Up France Sas | $17.86 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.45 | 2021 | |
| Innovation Technologies INC | $17.37 | 2025 | Irrisept |
| Lupin INC. | $17.02 | 2020 | |
| Amgen INC. | $16.58 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.82 | 2022 | |
| Exact Sciences Corporation | $14.04 | 2023 | Cologuard Collection Kit |
| Renovia INC | $13.47 | 2019 | |
| Agile Therapeutics, INC. | $13.20 | 2023 | Twirla |
| Minerva Surgical, INC | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherri Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.